By Bowman Cox 26 Jul 2021
Industry requests for deadline extensions, short-duration adjustments and other accommodations go nowhere as FDA expresses concerns about nitrosamines’ mutagenic potency.
Entries are now open for the Global Generics & Biosimilars Awards 2019, which will this year be presented on Tuesday 5 November at the Frankfurt Marriott Hotel in Frankfurt, Germany.
Now in their sixth year, the Awards – which are free to enter and attend – have added two new categories to the roster for 2019: Value Added Medicine Of The Year and Legal Strategy Of The Year.
Entries in the Value Added Medicine Of The Year category could include known molecules that are repurposed for new indications, reformulated in a way that adds value for patients, put together in innovative combinations, or which feature added-value packaging or delivery methods.
Meanwhile, the Legal Strategy Of The Year category allows generics, biosimilars and value-added medicines firms as well as their partnering law firms to highlight outstanding results from their legal strategy. This could include notable litigation results allowing a competitive advantage or early launch; inventive ways of getting around or invalidating intellectual property; or ways in which legal strategies from different global jurisdictions have been used as a template elsewhere, showing the benefits of a co-ordinated international legal strategy.
Companies and individuals involved in the generics, biosimilars and value added medicines industries can submit by 9 August 2019 their entries for all 14 awards, which will be judged by expert panels.
Awards available for entry include the Company of the Year Award as well as three local Company of the Year Awards for the Americas, EMEA and Asia-Pacific regions.
Other Awards include the Business Development of the Year Award – sponsored by West Pharma – as well as the Acquisition of the Year, API Supplier of the Year, Biosimilar Initiative of the Year, Regulatory Achievement of the Year and Industry Partner of the Year Awards.
Company leadership will be recognized by the Leader of the Year Award, while International Health Partners (IHP) will once again sponsor the Award for Corporate Social Responsibility (CSR) Initiative of the Year.
For more information an to enter the awards, please follow this link.
To book tables and to enquire about sponsorship opportunities, please e-mail firstname.lastname@example.org
To request tickets to attend the awards, and for any further details, please e-mail email@example.com
By Dean Rudge 26 Jul 2021
Having a year ago radically altered its business by offloading operations in India to rival Dr Reddy’s, India’s Wockhardt saw...
26 Jul 2021
The AAM’s latest study reveals that the Medicare Part D program continues to underperform compared to commercial plans in providing...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: